Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 2191 AL 2205

Adult-onset myoclonus ataxia associated with the mitochondrial m.8993T>C "NARP" mutation

Martikainen MH, Gorman GS, Goldsmith P, Burn DJ, Turnbull DM, Schaefer AM.

Mov Disord. 2015 Sep;30(10):1432-3. doi: 10.1002/mds.26358. Epub 2015 Aug 12.

A child with myoclonus-dystonia (DYT11) misdiagnosed as atypical opsoclonus myoclonus syndrome

Drivenes B, Born AP, Ek J, Dunoe M, Uldall PV.

Eur J Paediatr Neurol. 2015 Nov;19(6):719-21. doi: 10.1016/j.ejpn.2015.07.010. Epub 2015 Jul 29.

Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome Associated With Anti-N-methyl-D-aspartate Receptor Encephalitis

Player B, Harmelink M, Bordini B, Weisgerber M, Girolami M, Croix M.

Pediatr Neurol. 2015 Nov;53(5):456-8. doi: 10.1016/j.pediatrneurol.2015.07.010. Epub 2015 Aug 1.

[Neuropsychiatric manifestations ushering pernicious anemia]

Mrabet S, Ellouze F, Ellini S, Mrad MF.

Encephale. 2015 Dec;41(6):550-5. doi: 10.1016/j.encep.2015.07.004. Epub 2015 Sep 4.

New insights into the pathogenesis and therapeutics of episodic ataxia type 1

D'Adamo MC, Hasan S, Guglielmi L, Servettini I, Cenciarini M, Catacuzzeno L, Franciolini F.

Front Cell Neurosci. 2015 Aug 19;9:317. doi: 10.3389/fncel.2015.00317. eCollection 2015.

Visual symptoms in the presentation of Creutzfeldt-Jakob disease

Wong A, Matheos K, Danesh-Meyer HV.

J Clin Neurosci. 2015 Oct;22(10):1688-9. doi: 10.1016/j.jocn.2015.05.006.

[A Case of Sporadic Creutzfeldt-Jakob Disease That Developed With Psychiatric Symptoms]

Özkan A, Aydın Cantürk İ, Candan F, Işık N, Özışık Karaman HI.

Turk Psikiyatri Derg. 2015 Fall;26(3):213-6.

GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System

Gazulla J, Ruiz-Gazulla C, Tintore M.

Curr Pharm Des. 2015;21(34):4989-95. doi: 10.2174/1381612821666150914120923.

Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19 in patients with unknown spinocerebellar ataxia: a Thai multicentre study

Choubtum L, Witoonpanich P, Hanchaiphiboolkul S, Bhidayasiri R, Jitkritsadakul O, Pongpakdee S, Wetchaphanphesat S, Boonkongchuen P, Pulkes T.

BMC Neurol. 2015 Sep 15;15:166. doi: 10.1186/s12883-015-0425-y.

Rituximab treatment for relapsed opsoclonus-myoclonus syndrome

Toyoshima D, Morisada N, Takami Y, Kidokoro H, Nishiyama M, Nakagawa T, Ninchoji T, Nozu K, Takeshima Y, Takada S, Nishio H, Iijima K.

Brain Dev. 2016 Mar;38(3):346-9. doi: 10.1016/j.braindev.2015.09.002. Epub 2015 Sep 12.

Magnetic ressonance imaging in the diagnosis of Creutzfeldt-Jakob disease: Report of two cases

Valente AP, Pinho PDC, Lucato LT.

Dement Neuropsychol. 2015 Oct-Dec;9(4):424-427. doi: 10.1590/1980-57642015DN94000424.

Gluten Sensitivity - A Potentially Reversible Cause of Progressive Cerebellar Ataxia and Myoclonus - A Case Report

Khwaja GA, Bohra V, Duggal A, Ghuge VV, Chaudhary N.

J Clin Diagn Res. 2015 Nov;9(11):OD07-8. doi: 10.7860/JCDR/2015/13299.6743. Epub 2015 Nov 1.

Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient

Ghia T, Kanhangad M, Alessandri AJ, Price G, Gera P, Nagarajan L.

Pediatr Neurol. 2016 Feb;55:68-70. doi: 10.1016/j.pediatrneurol.2015.09.021. Epub 2015 Oct 23.

Primary pancreatic neuroblastoma presenting with opsoclonus-myoclonus syndrome

Galgano S, Royal S.

Radiol Case Rep. 2015 Nov 28;11(1):36-40. doi: 10.1016/j.radcr.2015.09.003. eCollection 2016 Mar.

Progressive myoclonus epilepsy: extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novel SCARB2 mutations

Fu YJ, Aida I, Tada M, Tada M, Toyoshima Y, Takeda S, Nakajima T, Naito H, Nishizawa M, Onodera O, Kakita A, Takahashi H.

Neuropathol Appl Neurobiol. 2014 Aug;40(5):551-63. doi: 10.1111/nan.12057.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias